Regulators forced to delay authorization of Baltimore plant’s production lines, the New York Times reports
About 15m doses of Johnson & Johnson’s Covid-19 vaccines have been ruined due to a mixup at a Baltimore plant, forcing regulators to delay authorization of the plant’s production lines, the New York Times newspaper reported on Wednesday.
The plant is run by Emergent BioSolutions, a manufacturing partner to both Johnson & Johnson and AstraZeneca Plc, according to the report.
